1. Home
  2. ACR vs STRO Comparison

ACR vs STRO Comparison

Compare ACR & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACR

ACRES Commercial Realty Corp.

N/A

Current Price

$12.48

Market Cap

146.1M

Sector

Real Estate

ML Signal

N/A

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

N/A

Current Price

$9.57

Market Cap

159.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ACR
STRO
Founded
2005
2003
Country
United States
United States
Employees
N/A
128
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
146.1M
159.5M
IPO Year
2005
2018

Fundamental Metrics

Financial Performance
Metric
ACR
STRO
Price
$12.48
$9.57
Analyst Decision
Buy
Strong Buy
Analyst Count
2
14
Target Price
$17.00
★ $47.23
AVG Volume (30 Days)
38.0K
★ 323.7K
Earning Date
11-04-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $79,946,000.00
$38,419,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$9.91
$0.72
52 Week High
$24.61
$43.85

Technical Indicators

Market Signals
Indicator
ACR
STRO
Relative Strength Index (RSI) 51.47 35.55
Support Level $9.91 $8.11
Resistance Level $14.97 $11.80
Average True Range (ATR) 0.75 0.82
MACD 0.23 0.25
Stochastic Oscillator 50.60 41.46

Price Performance

Historical Comparison
ACR
STRO

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding, and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralized debt obligations, and private equity investments mainly issued by financial institutions.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: